Clinical Trial Update: Real-Time Continuous Glucose Monitoring (RT-CGM) in Patients With Type 1 Diabetes at High Risk for Low Glucose Values Using Multiple Daily Injections (MDI) in Germany (HYPODE-STUDY) [NA]

View source ↗

Summary

This clinical trial update reports on real-time continuous glucose monitoring in adults with Type 1 diabetes at high risk of hypoglycemia using multiple daily i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Snippet

Sponsor: Science Consulting in Diabetes | Conditions: Diabetes | NA | Status: COMPLETED